NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
5.75
+0.04 (0.70%)
Mar 9, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $61.25 million as of March 9, 2026. Its market cap has increased by 269.50% in one year.
Market Cap
61.25M
Enterprise Value
57.37M
1-Year Change
269.50%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $61.25M, an increase of 233.41%. That is a compound annual growth rate of 59.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 61.25M | 26.65% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImageneBio | 63.05M |
| Mereo BioPharma Group | 62.32M |
| eXoZymes | 61.83M |
| Alterity Therapeutics | 61.33M |
| Entera Bio | 60.99M |
| Grace Therapeutics | 60.81M |
| Instil Bio | 60.36M |
| BeyondSpring | 60.24M |